GXP-PHARMA SUPPORT ApS: Financial statements 2019
CVR: 36033347
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,167,811 and a net result of DKK 328,406 compared with DKK 28,043 the year before. That is a decrease of 23% compared with the year before. Equity in the 2019 report amounted to DKK 1,428,116. The solvency ratio was 48.9%.
- Gross Profit
- DKK 1,167,811
- Profit/Loss
- DKK 328,406
- Equity
- DKK 1,428,116
- Total Assets
- DKK 2,922,514
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.2 mio. | 328 t. | 1.4 mio. | - |
| 2018 | - | 1.5 mio. | 28 t. | 1.1 mio. | - |
| 2017 | - | 1.1 mio. | 424 t. | 1.9 mio. | - |
| 2016 | - | 1.5 mio. | 154 t. | 1.4 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GXP-PHARMA SUPPORT ApS has published its annual report for 2018. Gross profit came to DKK 1,517,034, and the net result was DKK 28,043.
As of May 10, 2019, DANSK REVISION SLAGELSE GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of GXP-PHARMA SUPPORT ApS.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.